BIOTECHNOLOGY VALUE FUND L P - 06 Nov 2025 SCHEDULE 13D/A Report for MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share
Symbol
MLTX
Shares outstanding
71,304,274 shares
Disclosed Ownership
19,751,284 shares
Ownership
28%
Form type
SCHEDULE 13D/A
Filing time
10 Nov 2025, 17:27:37 UTC
Date of event
06 Nov 2025
SEC
View on sec.gov

Reporting Managers (11)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 14% 10,235,089 0 10,235,089 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 14% 10,235,089 0 10,235,089 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 11% 8,168,838 0 8,168,838 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 11% 8,168,838 0 8,168,838 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 1.8% 1,287,768 0 1,287,768 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 1.8% 1,287,768 0 1,287,768 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 26% 18,403,927 0 18,403,927 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 28% 19,751,284 0 19,751,284 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 28% 19,751,284 0 19,751,284 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 28% 19,751,284 0 19,751,284 /s/ Mark N. Lampert Mark N. Lampert 0001233840
Loy Spike 0.03% 18,985 18,985 0 /s/ Spike Loy Spike Loy 0001920549